Company Intelligence Profile
Gynoveda Femtech Private Limited
India's first Ayurveda FemTech company, blending Ayurvedic formulations and tech-enabled care for PCOS, fertility, and menstrual health.
Last updated 20 August 2026
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Gynoveda Femtech Private Limited |
|---|---|
| CIN | U85300MH2019PTC327679 |
| PAN | AAHCG8940P — Source: Tofler |
| Status | Active (Private, non-govt company) — Source: Tofler, TheCompanyCheck |
| Listing | Unlisted / not listed on any stock exchange — Source: Tofler, TheCompanyCheck (private limited company) |
| Incorporated | 05 July 2019 — Source: Tofler, TheCompanyCheck (agree) |
| ROC | RoC Mumbai, Maharashtra — Source: TheCompanyCheck |
| Sector (NIC) | Manufacture of pharmaceuticals, medicinal chemical and botanical products (Chemicals & chemical products / pharma NIC classification, code family ~21002); business also described as IVF/maternity/fertility care centres — Source: Tofler, TheCompanyCheck |
| Registered address | Accesswork, Level 9 – A Wing, Eureka Towers, Mindspace, Malad (West), Mumbai, Maharashtra – 400064 — Source: Tofler, TheCompanyCheck (agree) |
| Authorized capital | ₹14.48 crore — Source: Tofler, TheCompanyCheck (agree) |
| Paid-up capital | ₹13.69 crore (Issued & Subscribed also ₹13.69 Cr) — Source: Tofler, TheCompanyCheck (agree) |
Business Overview
Partial / conflicting- Gynoveda is India's first "Ayurveda FemTech" company, founded in 2019 by Rachana Gupta and Vishal Gupta, combining Ayurvedic formulations with technology/telehealth to address PCOS/PCOD, fertility, and menstrual health issues
- It operates D2C herbal/nutraceutical product lines alongside physical fertility/IVF and maternity-care clinics across multiple Indian cities (Mumbai, Delhi, etc.), and runs an e-commerce platform (gynoveda.com) with claimed 27,000+ Google reviews at 4.7 rating
- Actor Taapsee Pannu is a brand ambassador/investor-adjacent public face per startup-media coverage. — Source: TheCompanyCheck, gynoveda.com, Startup Intros/Inc42-style aggregated coverage
Directors & DINs
Partial / conflicting| Name | DIN | Role | Appointed |
|---|---|---|---|
| Vishal Sudhir Gupta | 07030219 | - | 05 Jul 2019 |
| Rachana Vishal Gupta | 08502069 | - | 05 Jul 2019 |
| Vinay Singh | 07322458 | - | 14 Mar 2020 |
| Shivani Bhasin (Sachdeva) | 00590500 | date conflict) | - |
GST Registrations
Partial / conflicting| GSTIN | State | PAN | Status |
|---|---|---|---|
| 27AAHCG8940P1ZT | Maharashtra | AAHCG8940P — Source: Tofler | - |
| 07AAHCG8940P1ZV | Delhi | AAHCG8940P — Source: Tofler | - |
| 22AAHCG8940P1Z3 | Chhattisgarh | AAHCG8940P — Source: Tofler | - |
| 09AAHCG8940P1ZR | Uttar Pradesh | AAHCG8940P — Source: Tofler | - |
Primary/registered PAN for GST: AAHCG8940P (matches company PAN). Multi-state registrations found via knowyourgst.com-sourced aggregation: - Maharashtra (home state): 27AAHCG8940P1ZT - Delhi: 07AAHCG8940P1ZV - Chhattisgarh: 22AAHCG8940P1Z3 - Uttar Pradesh: 09AAHCG8940P1ZR Number of registrations: at least 4 identified (likely more given pan-India clinic/warehouse footprint, not fully enumerated). Status: not independently confirmed as Active per-registration (source aggregation didn't expose individual status flags) — treat as partial confidence, single-source (knowyourgst.com via search aggregation, not the individual GSTIN page directly).
Financials
Partial / conflictingFY2025 (year ended 31 Mar 2025), standalone:
- Revenue: ₹68.14 crore, described as "₹50-75 crore" operating revenue band by Tofler — roughly consistent
- Revenue growth: ~1.00% YoY
- Net worth: declined -11.8% YoY
- Borrowings: increased 279.52% YoY
- EBITDA, PAT: not obtained
- Consolidated vs standalone: not specified; appears standalone company-level filing
Tofler, TheCompanyCheck
Funding
Partial / conflictingTotal raised: approx. $10.9M–$11M across 3 rounds, though Inc42 Datalabs cites a much higher "$71.00 Mn+" figure — SOURCE CONFLICT, not reconciled.
| Seed round | ~$1 million in 2019 |
|---|---|
| Series A | $10 million in March 2023, led by India Alternatives |
| Investors named across sources | India Alternatives, DS Group, Alteria Capital; Taapsee Pannu associated as brand ambassador (not confirmed as equity investor) |
Tracxn (round names/investors), Startup Intros/secondary startup-media aggregation (amounts) — confidence: partial, not from a single authoritative primary filing
Charges & Borrowings
Partial / conflictingOpen charges totaling ₹16 crore; Satisfied charges ₹2 crore; most recent charge of ₹10 crore registered 22 Sep 2025. ICICI Bank Limited — ₹5.0 crore charge; Orbis Trusteeship Services Private Limited — ₹3.6 crore charge. the two sources' charge totals do not fully reconcile (₹16 Cr open vs. ₹5+3.6=8.6 Cr itemized) — likely reflects additional/updated charges filed since Tofler's snapshot; flagged as a data-currency gap, not a contradiction.
Competitors
Partial / conflictingFrequently Asked Questions
What does Gynoveda Femtech Private Limited do?
What is the CIN of Gynoveda Femtech Private Limited?
Where is Gynoveda Femtech Private Limited registered?
When was Gynoveda Femtech Private Limited incorporated?
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.